Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-02-17 @ 8:38 PM
Study NCT ID:
NCT03920657
Status:
TERMINATED
Last Update Posted:
2022-11-21
First Post:
2018-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS
Sponsor:
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-14
First Submit QC Date:
None
Study First Post Date:
2019-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-16
Last Update Post Date:
2022-11-21
Last Update Post Date Type:
ACTUAL